Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook




 

Genetic mapping reveals origins of cancer

19 August 2013

By Dr Sarah Spain

Appeared in BioNews 718

A team of researchers has comprehensively charted the genetic 'signatures' of processes that drive tumour development for the first time.

Scientists analysed more than 7,000 genomes and found almost five million mutations from the most common cancers. The processes that cause cancer - such as exposure to cigarette smoke - cause certain mutation patterns, described by the researchers as genetic signatures, highlighting the biological pathways involved in tumour development.

'Our map of the events that cause the majority of cancers in humans is an important step to discovering the processes that drive cancer formation', said Dr Serena Nik-Zainal, study author from the Wellcome Trust Sanger Institute. 'Through detailed analysis, we can start to use the overwhelming amounts of information buried deep in the DNA of cancers to our advantage in terms of understanding how and why cancers arise'.

All cancers are caused by somatic mutations in the DNA of cells in the body – that is, mutations that occur during a person's lifetime. The mutational processes identified by this study were able to explain most of the DNA changes found in 30 of the most common cancers.

Signatures were identified for processes that are well understood, such as tobacco smoke causing mutations that lead to lung cancer, and ultraviolet light in skin cancer. Other signatures were for ageing related processes, immune system processes and processes for repairing damaged DNA. However, 12 of the signatures were as yet unexplained.

'We have uncovered the archaeological traces within cancer genomes of the diverse mutational processes that lead to the development of most cancers', said Professor Sir Mike Stratton, Director of the Wellcome Trust Sanger Institute, who led the study. 'This compendium of mutational signatures and the consequent insights into the mutational processes underlying them has profound implications for the understanding of cancer development with potential applications in disease prevention and treatment'.

The team found that in more than half of the cancers studied, tumour development was linked to a group of enzymes, known as APOBECs, which are known to mutate DNA. These enzymes are activated in response to some viral infections to protect cells. The researchers suggested that these signatures may be the result of collateral damage to the genome caused by the activation of the enzymes.

Cancer Research UK welcomed the findings, with chief scientist Professor Nic Jones saying: 'The genetic fingerprints identified in this fascinating and important study identify several new processes driving the development of cancer. Understanding what's causing them could be an extremely important way to get to the bottom of how cancer develops in the first place – and this will lead to new ways to treat and prevent the disease'.

SOURCES & REFERENCES
Wellcome Trust Sanger Institute (press release) | 14 August 2013
 
Reuters | 14 August 2013
 
BBC News | 14 August 2013
 
NHS Choices | 15 August 2013
 
Nature | 14 August 2013
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

04 August 2014 - by Daryl Ramai 
Scientists at the Children's Nutrition Research Center, USA have shown that epigenetic changes alone could cause cancer....
27 January 2014 - by Dr Barbara Kramarz 
Scientists have sequenced the DNA of the hookworm, a parasite that feeds on blood in the human digestive tract...
30 September 2013 - by Daryl Ramai 
Molecular similarities among different tumour types have been identified, revealing new ways to classify cancer...

22 July 2013 - by Maren Urner 
The world's largest database of cancer-related genetic variations to date has been made available by the National Cancer Institute (NCI), US...
28 May 2013 - by Dr Shanya Sivakumaran 
A genetic testing programme that will look for nearly 100 cancer risk genes has been launched, in the hope that genetic tests will become routine for cancer patients across the UK....
07 May 2013 - by Suzanne Elvidge 
Genetic analysis of tumours provides the key to treating them effectively, according to two studies carried out by The Cancer Genome Atlas (TCGA)....
08 April 2013 - by Siobhan Chan 
The largest ever study into cancer genes has identified more than 80 genetic markers for breast, prostate and ovarian cancer....

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust
Advertise your products and services HERE - click for further details

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation